In vitro activity of gentamicin, vancomycin or amikacin combined with EDTA or L-arginine as lock therapy against a wide spectrum of biofilm-forming clinical strains isolated from catheter-related infections

Journal of Antimicrobial Chemotherapy

Volumn 70, Issue 6, 2014, Pages 1704-1712

  Lebeaux, David ^a,b   Leflon Guibout, Véronique ^c   Ghigo, Jean Marc ^a   Beloin, Christophe ^a  

^a INSTITUT PASTEUR   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c BEAUJON HOSPITAL   (France)

Author keywords

Adjuvant strategy; Aminoglycosides; Antibiotic lock therapy; In vitro models; Persisters

Indexed keywords

AMIKACIN; ARGININE; EDETATE DISODIUM; GENTAMICIN; VANCOMYCIN; ANTIINFECTIVE AGENT; CHELATING AGENT; EDETIC ACID;

ARTICLE; BACTERIAL STRAIN; BACTERIAL SURVIVAL; BACTERICIDAL ACTIVITY; BACTERIUM ISOLATION; BIOFILM; CATHETER INFECTION; COLONY FORMING UNIT; CONTROLLED STUDY; ENTEROBACTER CLOACAE; ENTEROBACTERIACEAE INFECTION; ENTEROCOCCAL INFECTION; ENTEROCOCCUS FAECALIS; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTION; IN VITRO STUDY; KLEBSIELLA PNEUMONIAE; KLEBSIELLA PNEUMONIAE INFECTION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PROSPECTIVE STUDY; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTION; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; STAPHYLOCOCCUS INFECTION; STAPHYLOCOCCUS LUGDUNENSIS; BACTERIAL COUNT; BACTERIUM; DISINFECTION; DRUG EFFECTS; HUMAN; ISOLATION AND PURIFICATION; MICROBIAL VIABILITY; MICROBIOLOGY; PROCEDURES;

AMIKACIN; ANTI-INFECTIVE AGENTS; ARGININE; BACTERIA; BIOFILMS; CATHETER-RELATED INFECTIONS; CHELATING AGENTS; COLONY COUNT, MICROBIAL; DISINFECTION; EDETIC ACID; GENTAMICINS; HUMANS; MICROBIAL VIABILITY; VANCOMYCIN;

EID: 84930514208     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkv044     Document Type: Article

References (34)

1. Messing B, Peitra-Cohen S, Debure A et al. Antibiotic-lock technique: a new approach to optimal therapy for catheter-related sepsis in homeparenteral nutrition patients. JPEN J Parenter Enteral Nutr 1988;12:185-9.
2. Fernandez-Hidalgo N, Almirante B, Calleja R et al. Antibiotic-lock therapy for long-term intravascular catheter-related bacteraemia: results of an open, non-comparative study. J Antimicrob Chemother 2006;57:1172-80.
3. Fortun J, Grill F,Martin-Davila P et al. Treatment of long-termintravascular catheter-related bacteraemia with antibiotic-lock therapy. J Antimicrob Chemother 2006;58:816-21.
4. Lebeaux D, Fernandez-Hidalgo N, Chauhan A et al. Management of infections related to totally implantable venous-access ports: challenges and perspectives. Lancet Infect Dis 2014;14:146-59.
5. Costerton JW, Stewart PS, Greenberg EP. Bacterial biofilms: a common cause of persistent infections. Science 1999;284:1318-22.
6. Lebeaux D, Ghigo JM, Beloin C. Biofilm-related infections: bridging the gap between clinical management and fundamental aspects of recalcitrance toward antibiotics. Microbiol Mol Biol Rev 2014;78:510-43.
7. Lewis K. Multidrug tolerance of biofilms and persister cells. Curr Top Microbiol Immunol 2008;322:107-31.
8. Mermel LA, Allon M, Bouza E et al. Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection:2009 update by the Infectious Diseases Society of America. Clin Infect Dis 2009;49:1-45.
9. Reimund JM, Arondel Y, Finck G et al. Catheter-related infection in patients on home parenteral nutrition: results of a prospective survey. Clin Nutr 2002;21:33-8.
10. Rijnders BJ, Van Wijngaerden E, Vandecasteele SJ et al. Treatment of long-term intravascular catheter-related bacteraemia with antibiotic lock: randomized, placebo-controlled trial. J Antimicrob Chemother 2005;55:90-4.
11. Funalleras G, Fernandez-Hidalgo N, Borrego A et al. Effectiveness of antibiotic-lock therapy for long-term catheter-related bacteremia due to Gram-negative bacilli: a prospective observational study. Clin Infect Dis 2011;53: e129-32.
12. Chauhan A, Lebeaux D, Ghigo JM et al. Full and broad-spectrum in vivo eradication of catheter-associated biofilms using gentamicin-EDTA antibiotic lock therapy. Antimicrob Agents Chemother 2012;56:6310-8.
13. Lebeaux D, Chauhan A, Letoffe S et al. pH-mediated potentiation of aminoglycosides kills bacterial persisters and eradicates in vivo biofilms. J Infect Dis 2014;210:1357-66.
14. Turakhia MH, Cooksey KE, Characklis WG. Influence of a calciumspecific chelant on biofilm removal. Appl Environ Microbiol 1983;46:1236-8.
15. Bookstaver PB, Williamson JC, Tucker BK et al. Activity of novel antibiotic lock solutions in a model against isolates of catheter-related bloodstream infections. Ann Pharmacother 2009;43:210-9.
16. Raad II, Fang X, Keutgen XM et al. The role of chelators in preventing biofilm formation and catheter-related bloodstream infections. Curr Opin Infect Dis 2008;21:385-92.
17. Chauhan A, Lebeaux D, Decante B et al. A rat model of central venous catheter to study establishment of long-term bacterial biofilm and related acute and chronic infections. PLoS One 2012;7: e37281.
18. Lebeaux D, Larroque B, Gellen-Dautremer J et al. Clinical outcome after a totally implantable venous access port-related infection in cancer patients: a prospective study and review of the literature. Medicine (Baltimore) 2012;91:309-18.
19. Hulten KG, Kaplan SL, Lamberth LB et al. Hospital-acquired Staphylococcus aureus infections at Texas Children's Hospital, 2001-2007. Infect Control Hosp Epidemiol 2010;31:183-90.
20. Zhanel GG, DeCorby M, Laing N et al. Antimicrobial-resistant pathogens in intensive care units in Canada: results of the Canadian National Intensive Care Unit (CAN-ICU) study, 2005-2006. Antimicrob Agents Chemother 2008;52:1430-7.
21. Bertani G. Lysogeny at mid-twentieth century: P1, P2, and other experimental systems. J Bacteriol 2004;186:595-600.
22. Clinical and Laboratory Standards Institute. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically-Eighth Edition: Approved Standard M07-A8. CLSI, Wayne, PA, USA, 2009.
23. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing: Twentieth Informational Supplement M100-S20. CLSI, Wayne, PA, USA, 2010.
24. Bernier SP, Lebeaux D, DeFrancesco AS et al. Starvation, together with the SOS response, mediates high biofilm-specific tolerance to the fluoroquinolone ofloxacin. PLoS Genet 2013;9: e1003144.
25. Banin E, Brady KM, Greenberg EP. Chelator-induced dispersal and killing of Pseudomonas aeruginosa cells in a biofilm. Appl Environ Microbiol 2006;72:2064-9.
26. Lippi G, Plebani M. EDTA-dependent pseudothrombocytopenia: further insights and recommendations for prevention of a clinically threatening artifact. Clin Chem Lab Med 2012;50:1281-5.
27. Barbier F, Lebeaux D, Hernandez D et al. High prevalence of the arginine catabolic mobile element in carriage isolates of methicillinresistant Staphylococcus epidermidis. J Antimicrob Chemother 2011;66:29-36.
28. Diep BA, Otto M. The role of virulence determinants in communityassociated MRSA pathogenesis. Trends Microbiol 2008;16:361-9.
29. Miragaia M, de Lencastre H, Perdreau-Remington F et al. Genetic diversity of arginine catabolic mobile element in Staphylococcus epidermidis. PLoS One 2009;4: e7722.
30. Planet PJ, LaRussa SJ, Dana A et al. Emergence of the epidemic methicillin-resistant Staphylococcus aureus strain USA300 coincides with horizontal transfer of the arginine catabolic mobile element and speGmediated adaptations for survival on skin. MBio 2013;4: e00889-13.
31. von Eiff C, Reinert RR, Kresken M et al. Nationwide German multicenter study on prevalence of antibiotic resistance in staphylococcal bloodstream isolates and comparative in vitro activities of quinupristin-dalfopristin. J Clin Microbiol 2000;38:2819-23.
32. Curtin J, Cormican M, Fleming G et al. Linezolid compared with eperezolid, vancomycin, and gentamicin in an in vitro model of antimicrobial lock therapy for Staphylococcus epidermidis central venous catheterrelated biofilm infections. Antimicrob Agents Chemother 2003;47:3145-8.
33. Lee JY, Ko KS, Peck KR et al. In vitro evaluation of the antibiotic lock technique (ALT) for the treatment of catheter-related infections caused by staphylococci. J Antimicrob Chemother 2006;57:1110-5.
34. Fernández-Hidalgo N, Gavaldà J, Almirante B et al. Evaluation of linezolid, vancomycin, gentamicin and ciprofloxacin in a rabbit model of antibiotic-lock technique for Staphylococcus aureus catheter-related infection. J Antimicrob Chemother 2010;65:525-30.